Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5

Reactivation of Retinopathy of Prematurity After Bevacizumab Injection

(2012) Jennifer Hu et al.   ARCHIVES OF OPHTHALMOLOGY

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review

(2011) Anna-Lena Hård et al.   ACTA PAEDIATRICA

Outcomes of a Protocol-Based Management for Zone 1 Retinopathy of Prematurity: The Indian Twin Cities ROP Screening Program Report Number 2

(2011) Subhadra Jalali et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Use of intravitreal anti-VEGF: Retinopathy of prematurity surgeons′ in Hamlet′s dilemma?

(2011) Rajvardhan Azad   INDIAN JOURNAL OF OPHTHALMOLOGY

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

(2011) Helen A. Mintz-Hittner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity

(2010) L-O Atchaneeyasakul et al.   Journal of Perinatology

Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan

(2010) Wei-Chi Wu et al.   OPHTHALMOLOGY

A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity

(2009) Jonathan A. Micieli et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Antivascular endothelial growth factor for retinopathy of prematurity

(2009) Helen A Mintz-Hittner et al.   CURRENT OPINION IN PEDIATRICS

Pathogenesis of retinopathy of prematurity and possible preventive strategies

(2008) Brian W. Fleck et al.   EARLY HUMAN DEVELOPMENT

Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity

(2008) Shigeru Honda et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) FOR TREATMENT OF STAGE 3 RETINOPATHY OF PREMATURITY IN ZONE I OR POSTERIOR ZONE II

(2008) HELEN A. MINTZ-HITTNER et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES